The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Official Title: A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination With Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304
Study ID: NCT02656303
Brief Summary: The purpose of this study was to provide the opportunity to the participants who progressed on treatment arm previously in the study UTX-TGR-304 (NCT02612311) to receive ublituximab (TG-1101) treatment in combination with umbralisib (TGR-1202).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
TG Therapeutics Investigational Trial Site, Huntsville, Alabama, United States
TG Therapeutics Investigational Trial Site, Chandler, Arizona, United States
TG Therapeutics Investigational Trial Site, Fayetteville, Arkansas, United States
TG Therapeutics Investigational Trial Site, Duarte, California, United States
TG Therapeutics Investigational Trial Site, Pleasanton, California, United States
TG Therapeutics Investigational Trial Site, San Diego, California, United States
TG Therapeutics Investigational Trial Site, Whittier, California, United States
TG Therapeutics Investigational Trial Site, Aurora, Colorado, United States
TG Therapeutics Investigational Trial Site, Denver, Colorado, United States
TG Therapeutics Investigational Trial Site, Bridgeport, Connecticut, United States
TG Therapeutics Investigational Trial Site, New Haven, Connecticut, United States
TG Therapeutics Investigational Trial Site, Stamford, Connecticut, United States
TG Therapeutics Investigational Trial Site, Newark, Delaware, United States
TG Therapeutics Investigational Trial Site, Boca Raton, Florida, United States
TG Therapeutics Investigational Trial Site, Fort Myers, Florida, United States
TG Therapeutics Investigational Trial Site, Jacksonville, Florida, United States
TG Therapeutics Investigational Trial Site, Jacksonville, Florida, United States
TG Therapeutics Investigational Trial Site, Saint Petersburg, Florida, United States
TG Therapeutics Investigational Trial Site, Tallahassee, Florida, United States
TG Therapeutics Investigational Trial Site, West Palm Beach, Florida, United States
TG Therapeutics Investigational Trial Site, Albany, Georgia, United States
TG Therapeutics Investigational Trial Site, Chicago, Illinois, United States
TG Therapeutics Investigational Trial Site, Peoria, Illinois, United States
TG Therapeutics Investigational Trial Site, Swansea, Illinois, United States
TG Therapeutics Investigational Trial Site, Urbana, Illinois, United States
TG Therapeutics Investigational Trial Site, Fort Wayne, Indiana, United States
TG Therapeutics Investigational Trial Site, Indianapolis, Indiana, United States
TG Therapeutics Investigational Trial Site, Westwood, Kansas, United States
TG Therapeutics Investigational Trial Site, Louisville, Kentucky, United States
TG Therapeutics Investigational Trial Site, Worcester, Massachusetts, United States
TG Therapeutics Investigational Trial Site, Ann Arbor, Michigan, United States
TG Therapeutics Investigational Trial Site, Detroit, Michigan, United States
TG Therapeutics Investigational Trial Site, Jackson, Michigan, United States
TG Therapeutics Investigational Trial Site, Saint Louis Park, Minnesota, United States
TG Therapeutics Investigational Trial Site, Kansas City, Missouri, United States
TG Therapeutics Investigational Trial Site, Lincoln, Nebraska, United States
TG Therapeutics Investigational Trial Site, Lebanon, New Hampshire, United States
TG Therapeutics Investigational Trial Site, Morristown, New Jersey, United States
TG Therapeutics Investigational Trial Site, Glens Falls, New York, United States
TG Therapeutics Investigational Trial Site, Syracuse, New York, United States
TG Therapeutics Investigational Trial Site, Charlotte, North Carolina, United States
TG Therapeutics Investigational Trial Site, Durham, North Carolina, United States
TG Therapeutics Investigational Trial Site, Durham, North Carolina, United States
TG Therapeutics Investigational Trial Site, Hickory, North Carolina, United States
TG Therapeutics Investigational Trial Site, Kinston, North Carolina, United States
TG Therapeutics Investigational Trial Site, Washington, North Carolina, United States
TG Therapeutics Investigational Trial Site, Canton, Ohio, United States
TG Therapeutics Investigational Trial Site, Toledo, Ohio, United States
TG Therapeutics Investigational Trial Site, Portland, Oregon, United States
TG Therapeutics Investigational Trial Site, Portland, Oregon, United States
TG Therapeutics Investigational Trial Site, Springfield, Oregon, United States
TG Therapeutics Investigational Trial Site, Camp Hill, Pennsylvania, United States
TG Therapeutics Investigational Trial Site, Hershey, Pennsylvania, United States
TG Therapeutics Investigational Trial Site, Philadelphia, Pennsylvania, United States
TG Therapeutics Investigational Trial Site, Pittsburgh, Pennsylvania, United States
TG Therapeutics Investigational Trial Site, Pawtucket, Rhode Island, United States
TG Therapeutics Investigational Trial Site, Greenville, South Carolina, United States
TG Therapeutics Investigational Trial Site, Sioux Falls, South Dakota, United States
TG Therapeutics Investigational Trial Site, Chattanooga, Tennessee, United States
TG Therapeutics Investigational Trial Site, Nashville, Tennessee, United States
TG Therapeutics Investigational Trial Site, Fort Worth, Texas, United States
TG Therapeutics Investigational Trial Site, San Antonio, Texas, United States
TG Therapeutics Investigational Trial Site, Ogden, Utah, United States
TG Therapeutics Investigational Trial Site, Blacksburg, Virginia, United States
TG Therapeutics Investigational Trial Site, Charlottesville, Virginia, United States
TG Therapeutics Investigational Trial Site, Fort Belvoir, Virginia, United States
TG Therapeutics Investigational Trial Site, Seattle, Washington, United States
TG Therapeutics Investigational Trial Site, Spokane, Washington, United States
TG Therapeutics Investigational Trial Site, Wauwatosa, Wisconsin, United States
TG Therapeutics Investigational Trial Site, Ferrara, , Italy
TG Therapeutics Investigational Trial Site, Milan, , Italy
TG Therapeutics Investigational Trial Site, Milan, , Italy
TG Therapeutics Investigational Trial Site, Torino, , Italy
TG Therapeutics Investigational Trial Site, Chorzów, , Poland
TG Therapeutics Investigational Trial Site, Gdynia, , Poland
TG Therapeutics Investigational Trial Site, Kraków, , Poland
TG Therapeutics Investigational Trial Site, Lublin, , Poland
TG Therapeutics Investigational Trial Site, Słupsk, , Poland
TG Therapeutics Investigational Trial Site, Warszawa, , Poland
TG Therapeutics Investigational Trial Site, Warszawa, , Poland
TG Therapeutics Investigational Trial Site, Warszawa, , Poland
TG Therapeutics Investigational Trial Site, Warszawa, , Poland
TG Therapeutics Investigational Trial Site, Łódź, , Poland
TG Therapeutics Investigational Trial Site, London, , United Kingdom
TG Therapeutics Investigational Trial Site, Norwich, , United Kingdom
TG Therapeutics Investigational Trial Site, Sunderland, , United Kingdom
TG Therapeutics Investigational Trial Site, Wolverhampton, , United Kingdom